Recruiting
Investigational
A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments
Investigational
- Substances:–
Countries:
Spain
Spain- Participants:18–64 years
- Sponsor:ReproNovo ApS
Sponsor
ReproNovo ApS
Amagerfaelledvej 106, 2300 Copenhagen, Denmark
About the sponsor
ReproNovo ApS focuses on clinical research in assisted reproduction, with particular attention to women undergoing in vitro fertilisation and intracytoplasmic sperm injection. The funded studies are centred on reproductive tract function and treatment-related outcomes relevant to fertility care.
- IVF and ICSI patient populations
- Uterine contractility
- Reproductive pharmacology
Clinical activity in this area reflects interest in therapies intended to support reproductive procedures and improve understanding of uterine response in fertility settings.
Recruiting now
Ongoing trials
Clinical trials run by this sponsor – those enrolling participants first.
Country
City
Type of trial
Recruitment status
Quick filters
1 clinical trial
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.